CVS Health Corporation ($CVS) Stock Forecast: Up 6.4% Today

What is CVS Health Corporation?

CVS Health (CVS) is a prominent healthcare company that operates pharmacies and provides health services. The stock had a bullish movement today amidst a focus on its recent earnings performance and market positioning within the healthcare sector.

Why is CVS Health Corporation going up?

CVS stock is up 6.4% on Jul 31, 2025 13:41

• CVS Health (CVS) exceeded both earnings and revenue estimates for the second quarter, showcasing strong financial performance and potentially indicating positive growth prospects.
• Analysts revised their expectations for CVS Health ahead of its earnings release, with a slight decrease in projected quarterly earnings per share compared to the previous year.
• Despite concerns about rising medical costs, CVS' Health Care Delivery unit demonstrated robust growth, driven by key partnerships with Signify and Oak Street, which likely contributed to investor optimism.
• The stock's recent slide amidst a rising market might be attributed to short-term fluctuations or profit-taking, rather than reflecting any fundamental issues with the company's performance.

CVS Price Chart

CVS Technical Analysis

CVS News

CVS Health ( CVS ) Beats Q2 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of +23.13% and +5.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2643097/cvs-health-cvs-beats-q2-earnings-and-revenue-estimates

Top Wall Street Forecasters Revamp CVS Health Expectations Ahead Of Q2 Earnings - CVS Health ( NYSE:CVS )

CVS Health Corporation CVS will release earnings results for the second quarter before the opening bell on Thursday, July 31. Analysts expect the Woonsocket, Rhode Island-based company to report quarterly earnings at $1.46 per share, down from $1.83 per share in the year-ago period.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46747934/top-wall-street-forecasters-revamp-cvs-health-expectations-ahead-of-q2-earning

Is CVS Health ( CVS ) Stock Outpacing Its Medical Peers This Year?

Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2638523/is-cvs-health-cvs-stock-outpacing-its-medical-peers-this-year

CVS Health Care Delivery: Will the Growth Momentum Last in Q2?

CVS' Health Care Delivery unit posts strong growth from Signify and Oak Street, but rising medical costs pose a near-term risk.

https://www.zacks.com/stock/news/2638083/cvs-health-care-delivery-will-the-growth-momentum-last-in-q2

CVS Health ( CVS ) Stock Slides as Market Rises: Facts to Know Before You Trade

In the most recent trading session, CVS Health (CVS) closed at $58.75, indicating a -5.01% shift from the previous trading day.

https://www.zacks.com/stock/news/2614344/cvs-health-cvs-stock-slides-as-market-rises-facts-to-know-before-you-trade

Trending Today

Shiba Inu ($SHIB) Crypto Forecast: Down 5.2% Today

XRP ($XRP) Crypto Forecast: Down 5.1% Today

Cardano ($ADA) Crypto Forecast: Down 5.1% Today

Chainlink ($LINK) Crypto Forecast: Down 5.4% Today

Lithia Motors Inc. ($LAD) Stock Forecast: Up 5.1% Today

ONEOK Inc. ($OKE) Stock Forecast: Down 5.0% Today

Transdigm Group Incorporated Inc. ($TDG) Stock Forecast: Down 12.7% Today

Eaton Corporation PLC ($ETN) Stock Forecast: Down 6.7% Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Up 7.2% Today

Pfizer Inc. ($PFE) Stock Forecast: Up 5.0% Today

CVS Health Corporation Price History

17.03.2025 - CVS Stock was down 7.2%

• CVS stock saw a decline of -0.55% and -1.87% in recent trading sessions.
• A comparison between CVS Health and UnitedHealth may have influenced investors' decisions, leading to some selling pressure on CVS stock.
• Uncertainty around healthcare policies and regulations may have also affected the bearish trend in CVS stock.
• Monitoring upcoming developments in the healthcare sector is crucial for investors to gauge the performance of CVS Health stock.

24.06.2025 - CVS Stock was down 5.1%

• Despite the anticipation of surpassing earnings expectations and encouraging indications of a possible revival, CVS stock faced a significant downtrend.
• The decrease in Q2 earnings predictions and worries regarding the company's performance might have overshadowed the positive developments, contributing to the market's bearish movement.
• Investors could have responded unfavorably to the uncertainties surrounding CVS's future performance, notwithstanding the company's efforts to enhance its Health Care Benefits division and potential signs of a turnaround.
• Despite the stock being technically oversold and receiving favorable evaluations from analysts, these factors may not have been sufficient to counterbalance the existing concerns, resulting in CVS's bearish trajectory today.

31.06.2025 - CVS Stock was up 6.4%

• CVS Health (CVS) exceeded both earnings and revenue estimates for the second quarter, showcasing strong financial performance and potentially indicating positive growth prospects.
• Analysts revised their expectations for CVS Health ahead of its earnings release, with a slight decrease in projected quarterly earnings per share compared to the previous year.
• Despite concerns about rising medical costs, CVS' Health Care Delivery unit demonstrated robust growth, driven by key partnerships with Signify and Oak Street, which likely contributed to investor optimism.
• The stock's recent slide amidst a rising market might be attributed to short-term fluctuations or profit-taking, rather than reflecting any fundamental issues with the company's performance.

01.04.2025 - CVS Stock was up 6.9%

• CVS Health outperformed expectations in the first quarter, prompting an increase in its full-year EPS guidance, which in turn boosted its stock value.
• A partnership with Novo Nordisk to improve access to Wegovy, a weight loss treatment, for CVS drug plan members played a role in boosting investor confidence.
• The company's strong financial results, highlighted by a sharp increase in adjusted EPS and operating income, bolstered the upward momentum of the stock.
• The market's positive reaction demonstrates faith in CVS's strategies and financial performance, leading to upward movement in the stock price even amidst market volatility.

01.04.2025 - CVS Stock was up 9.7%

• CVS Health (CVS) saw a notable upward movement in trading today.
• The company's Q1 earnings and revenues surpassed market expectations by a substantial margin, which likely instilled confidence among investors.
• The decision to prioritize Novo Nordisk's weight loss treatment Wegovy on its formulary may have also contributed to the positive market sentiment, hinting at potential growth avenues and improved healthcare offerings.
• Analysts' positive projections for CVS Health's earnings growth, along with the anticipation of a robust earnings performance, may have additionally bolstered the bullish momentum, attracting increased investor interest in the stock.

02.04.2025 - CVS Stock was down 4.4%

• CVS Health reported better-than-expected first-quarter results and raised its FY25 EPS guidance, leading to a sharp rise in its stock price.
• The partnership with Wegovy maker Novo Nordisk and the significant improvement in adjusted EPS and operating income contributed to the positive market sentiment towards CVS.
• The earnings and revenue beats in Q1 2025, along with the raised EPS view, further fueled investor confidence in CVS Health, driving the stock price higher.
• Despite the positive news and strong financial performance, the market might have reacted bearishly due to profit-taking or broader market factors impacting CVS's stock price negatively.

13.04.2025 - CVS Stock was down 5.2%

• The decline in CVS stock value could be linked to a recent executive order that aims to align U.S. drug prices with those of other countries, potentially impacting the company's financial performance.
• Although there were positive sentiments in options trading, the general market outlook has shifted negatively, resulting in the drop in CVS stock.
• Glenview Capital's remarks about CVS Health's progress in its long-term transformation might have been overshadowed by broader market anxieties, contributing to the stock's downturn.
• Investor perception of CVS Health compared to other industry peers may have also played a role in the stock price decrease.

13.04.2025 - CVS Stock was down 7.0%

• The bearish movement in CVS stock today could be attributed to investors potentially favoring Danaher (DHR) over CVS as a better value option in the Medical Services sector.
• Glenview Capital's statement on CVS Health may have failed to reassure investors about the company's long-term turnaround plans, leading to a lack of confidence in CVS stock.
• The overall sentiment in the market towards healthcare stocks might have also contributed to the bearish movement in CVS, as investors may be cautious about regulatory impacts and competitive pressures in the sector.

08.03.2025 - CVS Stock was up 8.7%

• CVS Health's recent appointment of a new CFO, along with strong Q4 sales that surpassed expectations, has instilled confidence among investors, resulting in a rise in the stock price.
• The company's consistent cash generation and impressive track record of earnings have positioned it well amidst broader market uncertainties, such as concerns about increasing tariffs.
• While there have been some bearish movements in the options market, the overall sentiment towards CVS Health remains positive, with a significant portion of traders displaying bullish inclinations.
• The temporary halt by the FTC on a lawsuit involving CVS Health, Cigna, and UnitedHealth's PBMs may have offered some relief to investors, contributing to the stock's upward trend.

13.01.2025 - CVS Stock was up 5.1%

• Upbeat earnings were reported by CVS Health for the fourth quarter, surpassing sales expectations and leading to a positive outlook from analysts.
• The company foresees 10% earnings growth for 2025, primarily driven by Aetna's recovery, which further bolstered investor confidence.
• The positive trend in earnings and growth outlook in the healthcare sector, as exemplified by companies like Coca-Cola, Pepsi, and Walgreens Boots Alliance, likely contributed to CVS's strong bullish movement today.
• Analyst upgrades and a favorable earnings outlook for the healthcare industry as a whole may have also influenced the upward movement of CVS's stock price.

04.03.2025 - CVS Stock was down 6.3%

• The bearish movement in CVS stock today may have been influenced by actions of financial giants in the options market, leading to increased bearish sentiment among traders.
• Despite CVS Health surpassing earnings expectations, market sentiment could have been impacted by the FTC's decision to halt a lawsuit involving CVS, Cigna, and UnitedHealth's PBMs, creating uncertainty for investors.
• Geopolitical events, tariff concerns, and Federal Reserve indecision might have further fueled the bearish outlook on CVS stock, overshadowing its strong earnings track record.

04.03.2025 - CVS Stock was down 5.5%

• The decision to pause the lawsuit against CVS, Cigna, and UnitedHealth's PBMs may have raised concerns among investors about potential regulatory challenges for CVS.
• The absence of technology stocks in the list of best-performing S&P 500 stocks could have shifted investor focus away from healthcare companies like CVS, leading to a bearish movement in the stock.
• The market's reaction suggests that investors are closely monitoring regulatory developments and industry trends, contributing to the downward pressure on CVS stock today.